Foresee Pharmaceuticals Co., Ltd. announced a private placement of 78,410 common shares at a price of $100 per share for the gross proceeds of $7,841,000 on may 3, 2024. The transaction has been approved by the shareholders of the company.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
97.1 TWD | +0.10% | -2.51% | +0.94% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.94% | 407M | |
+40.80% | 53.67B | |
+35.79% | 38.86B | |
-8.05% | 38.76B | |
-8.98% | 27.27B | |
+10.69% | 25.91B | |
-16.21% | 20.29B | |
+31.00% | 12.78B | |
+28.51% | 12.18B | |
-1.67% | 11.96B |
- Stock Market
- Equities
- 6576 Stock
- News Foresee Pharmaceuticals Co., Ltd.
- Foresee Pharmaceuticals Co., Ltd. announced that it expects to receive $7.841 million in funding